The Brihanmumbai Municipal Corporation (BMC) has relaunched its flagship public health initiative, the Aapli Chikitsa Yojana, on August 1, 2025, bringing affordable diagnostic services to Mumbaikars. This scheme, designed to make healthcare accessible and cost-effective, offers a wide range of blood tests at nominal rates across 100 civic-run health centers in Mumbai, with plans to expand to all BMC hospitals by August 15, 2025. By integrating modern technology, such as WhatsApp for report delivery and the Health Management Information System (HMIS) for data management, the initiative is set to transform healthcare accessibility for millions of residents in the bustling metropolis.
{tocify} $title={Table of Contents}
A Lifeline for Affordable Healthcare
Originally launched in 2019, the Aapli Chikitsa Yojana aims to provide high-quality diagnostic services at subsidized rates, particularly for those who cannot afford expensive private laboratory tests. After a seven-month hiatus due to the expiration of the previous contract in December 2024, the BMC has revitalized the program with renewed vigor. The scheme now operates in 100 health facilities, including 16 suburban hospitals, 30 maternity homes, five specialty hospitals, Dr. R.N. Cooper Hospital in Vile Parle, Hindu Hridaysamrat Balasaheb Thackeray (HHBT) Trauma Care Hospital in Jogeshwari, and municipal dispensaries across Wards A to E. This extensive network ensures that residents from various parts of Mumbai can access these services close to their homes.
 |
| BMC Aapli Chikitsa Yojana |
The initiative addresses a critical need in Mumbai, where the cost of medical diagnostics can be prohibitive for many, especially low-income families. By offering 83 blood tests—66 basic and 17 advanced—at nominal rates, the BMC is making essential healthcare services more inclusive. Basic tests, such as blood sugar, hemoglobin, urine analysis, liver function, kidney function, and thyroid profiles, are priced at approximately Rs 50, while advanced tests cost around Rs 100. These rates are significantly lower than those charged by private laboratories, making the scheme a game-changer for Mumbai’s economically disadvantaged communities.
BMC Aapli Chikitsa Yojana 2025 Highlights
| Highlight | Details |
|---|---|
| Scheme Name | BMC Aapli Chikitsa Yojana 2025 |
| Launch Date | August 1, 2025 |
| Coverage | 100 BMC health centers, expanding to all civic hospitals by August 15, 2025 |
| Tests Offered | 83 blood tests (66 basic, 17 advanced) |
| Test Costs | Basic: ~₹50, Advanced: ~₹100 |
| Service Provider | Lifenity Health Ltd |
| Report Delivery | Via WhatsApp, integrated with HMIS |
| Key Benefit | Affordable diagnostics for low-income families |
| Public Health Focus | Early detection of monsoon diseases (malaria, dengue, chikungunya) |
| Improvements | Digital integration, streamlined tests, reliable vendor |
Namo Shetkari Mahasanman Nidhi Yojana
Streamlined Operations and Digital Integration
One of the standout features of the relaunched Aapli Chikitsa Yojana is its embrace of technology to enhance efficiency and user experience. Patients can now receive their test reports directly via WhatsApp, eliminating the need for multiple visits to health centers to collect results. This digital upgrade not only saves time but also ensures that patients can promptly share their reports with healthcare providers for timely consultations. Additionally, all test data is integrated into the BMC’s Health Management Information System (HMIS), enabling seamless tracking and storage of patient records for future medical consultations at civic health facilities. This integration enhances patient care by ensuring continuity and accessibility of medical history across BMC institutions.
The scheme operates on an outsourced model, with Lifenity Health Ltd, a Pune-based company, appointed as the service provider following a competitive bidding process in June 2025. Lifenity Health secured the contract by offering basic tests at Rs 90, against the BMC’s estimated cost of Rs 100, ensuring cost-effectiveness without compromising quality. The company is responsible for conducting tests and delivering reports, maintaining high standards of accuracy and efficiency.
Krushi Samruddhi Yojana Maharashtra
Addressing Public Health Challenges
The relaunch of Aapli Chikitsa Yojana comes at a critical time, as Mumbai grapples with a surge in monsoon-related diseases such as malaria, dengue, and chikungunya. According to BMC’s July 2025 report, malaria cases nearly doubled to 4,151 compared to 2,852 in July 2024, while chikungunya cases surged fivefold, from 46 to 265. The availability of affordable diagnostic tests is crucial for early detection and treatment of these diseases, which can significantly reduce morbidity and mortality rates. The scheme’s focus on accessibility ensures that residents can get tested promptly, avoiding delays that could exacerbate health conditions.
The BMC has also intensified its public health measures, including vector control and health awareness campaigns, to complement the diagnostic services offered under Aapli Chikitsa. By combining affordable testing with proactive disease prevention, the BMC is taking a holistic approach to public health management in Mumbai.
Maharashtra Electric Vehicle Policy
Past Challenges and Future Improvements
While the Aapli Chikitsa Yojana has been largely successful, it has faced challenges in the past. In 2022, reports surfaced that VN Desai Hospital in Santacruz had unnecessarily outsourced basic tests to private labs, costing the BMC and Mumbaikars an additional Rs 1.37 crore. Such practices raised concerns about inefficiencies and potential malpractice, prompting calls for stricter oversight. Additionally, in 2023, the scheme faced disruptions when the previous service provider, Krsnaa Diagnostics, struggled to deliver timely results, highlighting the need for robust vendor management.
The BMC has addressed these issues in the 2025 relaunch by selecting a reliable service provider and implementing digital tools to enhance transparency and accountability. The reduction in the number of tests from 139 to 83 (101 basic and 38 advanced in 2019) reflects a strategic focus on the most essential diagnostics, ensuring quality and affordability without overburdening the system.
Impact on Mumbaikars
The Aapli Chikitsa Yojana is a testament to the BMC’s commitment to improving public health infrastructure in Mumbai. By offering affordable blood tests at 100 health centers, the scheme empowers residents to prioritize their health without financial strain. The initiative is particularly beneficial for below-poverty-line (BPL) families, who previously received free tests under the scheme and continue to benefit from its subsidized rates.
As the program expands to all civic hospitals by mid-August 2025, it is expected to serve an even larger population, reducing the burden on major hospitals like KEM and Bhabha. The combination of low-cost diagnostics, digital report delivery, and integration with HMIS positions Aapli Chikitsa as a model for public health initiatives in urban India.
Conclusion
The BMC’s Aapli Chikitsa Yojana 2025 is a beacon of hope for Mumbai’s residents, offering affordable and accessible blood tests at 100 health centers. With its digital innovations, strategic partnerships, and focus on public health, the scheme is poised to make a lasting impact on the city’s healthcare landscape. As Mumbai navigates the challenges of urbanization and seasonal diseases, initiatives like Aapli Chikitsa underscore the importance of equitable healthcare in building a healthier, more resilient city.
| Official Website | Click Here |
| Maharashtra Government Scheme | Click Here |
| Central Government Scheme | Click Here |
| Join Telegram | Telegram |
FAQs: BMC Aapli Chikitsa Yojana 2025
Q. What is the BMC Aapli Chikitsa Yojana 2025?
The BMC Aapli Chikitsa Yojana is a public health initiative by the Brihanmumbai Municipal Corporation (BMC) relaunched on August 1, 2025, to provide affordable blood tests at 100 civic-run health centers across Mumbai. It offers 83 types of blood tests (66 basic and 17 advanced) at nominal rates to make diagnostic services accessible to all residents, particularly low-income families.
Q. Where can I access the Aapli Chikitsa Yojana services?
The scheme is available at 100 BMC health facilities, including 16 suburban hospitals, 30 maternity homes, five specialty hospitals, Dr. R.N. Cooper Hospital in Vile Parle, Hindu Hridaysamrat Balasaheb Thackeray (HHBT) Trauma Care Hospital in Jogeshwari, and municipal dispensaries across Wards A to E. The program will expand to all BMC hospitals by August 15, 2025.
Q. What types of tests are offered under the scheme?
The scheme covers 83 blood tests, including:
- Basic tests (66 types): Blood sugar, hemoglobin, urine analysis, liver function, kidney function, thyroid profiles, etc.
- Advanced tests (17 types): Specialized diagnostics for complex conditions.
- These tests are designed to aid in the early detection of diseases like malaria, dengue, and chikungunya, which are prevalent during Mumbai’s monsoon season.
Q. How much do the tests cost?
- Basic tests cost approximately Rs 50.
- Advanced tests cost around Rs 100.
- These rates are significantly lower than private laboratory charges, making diagnostics affordable for all Mumbaikars.
Q. Who can benefit from this scheme?
The scheme is open to all Mumbai residents, with a special focus on low-income and below-poverty-line (BPL) families. BPL patients may receive additional benefits, such as free or further subsidized tests, depending on BMC policies.
Q. How are test reports delivered?
Test reports are delivered digitally via WhatsApp, ensuring convenience and eliminating the need for patients to revisit health centers to collect results. Reports are also integrated into the BMC’s Health Management Information System (HMIS) for seamless access during future consultations at civic health facilities.
Q. Why was the scheme relaunched in 2025?
The program was paused for seven months after the previous contract with Krsnaa Diagnostics expired in December 2024. The BMC relaunched it in August 2025 to address the rising need for affordable diagnostics, especially amid a surge in monsoon-related diseases like malaria and chikungunya.
Q. What improvements have been made in the 2025 relaunch?
Key improvements include:
- Digital integration: WhatsApp report delivery and HMIS data storage.
- Streamlined testing: Reduced from 139 to 83 tests to focus on essential diagnostics.
- Reliable service provider: Lifenity Health Ltd ensures timely and accurate results.
- Cost efficiency: Basic tests offered at Rs 90 against BMC’s estimated Rs 100.
Q. How can I locate the nearest health center offering these tests?
You can contact the BMC helpline or visit the official BMC website for a list of the 100 participating health centers. Local municipal dispensaries and hospitals in your ward are likely included.
Q. Are there plans to expand the scheme further?
Yes, the BMC plans to extend the Aapli Chikitsa Yojana to all civic-run hospitals by August 15, 2025, increasing accessibility across Mumbai.
Q. How does the scheme benefit low-income families?
By offering tests at Rs 50–100, the scheme reduces the financial burden on low-income families, who otherwise rely on costly private labs. BPL families may also qualify for free tests, enhancing healthcare equity.